Scarica l'app Stockscreener
1.63
0.00%
0.00
Opko Health Inc Borsa (OPK) Ultime notizie
SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.Therapy - Zacks Investment Research
FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI - Zacks Investment Research
GEHC Expands Theranostics Imaging With 5 Global Collaborations - Zacks Investment Research
Revvity Launches Signals LabGistics to Coordinate Scientific Workflows - Zacks Investment Research
3 Promising Penny Stocks With Over $200M Market Cap - Simply Wall Street
Greenberg Traurig Advises OPKO Health on $722M+ Agreement to Sell Select BioReference Health Assets to Labcorp - PR Newswire
H.C. Wainwright keeps USD 3.00 target for OPKO Health stock - AD HOC NEWS
OPKO Health (OPK) Sells BioReference Assets On A Valuation Story That Still Divides - Yahoo Finance
Barrington sets USD 2.25 target for OPKO Health stock - ad-hoc-news.de
Is OPKO Health (OPK) Pricing In Too Much For Sales? - Yahoo Finance
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M - Zacks Investment Research
Opko Health Inc. (OPK) Stock Price | Live Quotes & Charts | NASDAQ - Timothy Sykes
Piper Sandler raises Opko Health stock price target on LabCorp deal - Investing.com
OPKO Health (NASDAQ:OPK) Hits New 12-Month High Following Analyst Upgrade - MarketBeat
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M - Zacks Investment Research
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M - TradingView
Opko Health stock hits 52-week high at 1.75 USD By Investing.com - Investing.com Canada
Ladder Capital Posts Upbeat Q3 Earnings, Joins Alcoa, Hyster-Yale And Other Big Stocks Moving Higher On Friday - Benzinga
Opko Health stock hits 52-week high at 1.75 USD - Investing.com
H.C. Wainwright reiterates Opko Health stock rating on Labcorp deal By Investing.com - Investing.com Canada
OPKO HEALTH, INC. : BARRINGTON RESEARCH RAISES TO OUTPERFORM FROM MARKET PERFORM - Moomoo
OPKO Health (NASDAQ:OPK) Stock Rating Raised to Outperform at Barrington Research - MarketBeat
BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients - Zacks Investment Research
Why Is Opko Health Stock Gaining Thursday?OPKO Health (NASDAQ:OPK), Labcorp Holdings (NYSE:LH) - Benzinga
OPKO Health (NASDAQ:OPK) Shares Gap UpWhat's Next? - MarketBeat
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care - Zacks Investment Research
Penske Automotive, OPKO Health, Ericsson And Other Big Stocks Moving Higher On Thursday - Benzinga
OPK Stock Slides As Charts Flash Potential Pivot Zone - Timothy Sykes
Opko Health stock soars on $722M BioReference asset sale - Investing.com
OPK Stock Slides As Traders Weigh Weak Cash Flow And Support Levels - Timothy Sykes
Labcorp to buy select assets from Opko Health unit for up to $872 million - Reuters
OPK Stock Slips As Traders Weigh Weak Margins And Support Levels - StocksToTrade
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health - PR Newswire
A prostate cancer blood test may reach more patients if Labcorp completes its deal - Stock Titan
Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally? - Zacks Investment Research
BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026? - Zacks Investment Research
Reasons to Add QuidelOrtho Stock to Your Portfolio for Now - Zacks Investment Research
Hims & Hers Expands Australian Women's Health Platform With Hers - Zacks Investment Research
OPKO Health (NASDAQ:OPK) Share Price Breaks Below Fifty Day Moving AverageTime to Sell? - MarketBeat
Here's Why You Should Add Avantor Stock to Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain AMN Stock in Your Portfolio for Now - Zacks Investment Research
OPKO Health Q3 2026 Earnings Date and Estimates - MarketBeat
Bruker Gains 66.3% in a Year: What's Driving the Rally? - Zacks Investment Research
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research - Zacks Investment Research
Here's Why You Should Retain WAT Stock in Your Portfolio for Now - Zacks Investment Research
OPKO Health stock gets Zacks upgrade while shares fall 4.79 percent - AD HOC NEWS
BDX Expands U.S. Manufacturing With $19B Healthcare Investment - Zacks Investment Research
Reasons to Add Globus Medical Stock to Your Portfolio Now - Zacks Investment Research
OPKO Health (NasdaqGS:OPK) Stock Forecast & Analyst Predictions - Simply Wall Street
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now - TradingView
0.39%
1.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):